Cetera Investment Advisers
AMED

Cetera Investment Advisers’s Amedisys AMED Stock Holding History

Cetera Investment Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,277
Closed -$2.39M – 4571
2025
Q2 		$2.39M Buy
24,277
+2,728
+13% +$258K ﹤0.01% 1715
2025
Q1 		$2M Sell
21,549
-1,493
-6% -$138K ﹤0.01% 1750
2024
Q4 		$2.09M Sell
23,042
-1,316
-5% -$121K ﹤0.01% 1617
2024
Q3 		$2.35M Buy
24,358
+1,580
+7% +$154K 0.01% 1513
2024
Q2 		$2.09M Buy
22,778
+4,773
+27% +$443K ﹤0.01% 1539
2024
Q1 		$1.66M Buy
18,005
+4,917
+38% +$461K ﹤0.01% 1695
2023
Q4 		$1.24M Buy
13,088
+5,676
+77% +$530K 0.01% 980
2023
Q3 		$692K Buy
7,412
+1,611
+28% +$149K 0.01% 1255
2023
Q2 		$530K Buy
+5,801
New +$476K ﹤0.01% 1418
2022
Q1 		– Sell
-1,249
Closed -$202K – 1874
2021
Q4 		$202K Buy
+1,249
New +$201K ﹤0.01% 1734
2021
Q3 		– Sell
-1,592
Closed -$390K – 1789
2021
Q2 		$390K Sell
1,592
-753
-32% -$198K 0.01% 1258
2021
Q1 		$621K Sell
2,345
-300
-11% -$84.6K 0.01% 863
2020
Q4 		$776K Buy
+2,645
New +$678K 0.02% 768

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cetera Investment Advisers's AMED Position: Q3 2025 in Review

Cetera Investment Advisers sold out of Amedisys (AMED) in Q3 2025, closing a stake of 24,277 shares — an estimated $2.39M sold.

Cetera Investment Advisers first reported a position in AMED in Q4 2020 and held it in 13 quarters. The position peaked at $2.39M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cetera Investment Advisers reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 24,277 Amedisys shares in Q3 2025, an estimated $2.39M.
  • Cetera Investment Advisers first reported a position in Amedisys in Q4 2020 and held it in 13 quarters.
  • Cetera Investment Advisers's Amedisys position peaked at $2.39M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cetera Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.